President Trump takes fresh aim at the pharmaceutical sector, with a plan to levy 100% tariffs on generic drugs as he targets key areas ahead of the midterms.

U.S. President Donald Trump has revived his signature solution to many of his perceived problems: tariffs.

While the possibility of levies on branded pharmaceuticals have had a limited impact on drugmaker revenues, tariffs of up to 200% on copycat medicines could — depending on the…